tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Thermo Fisher’s Strong Market Position and Growth Drive Buy Rating

Thermo Fisher’s Strong Market Position and Growth Drive Buy Rating

Wells Fargo analyst Brandon Couillard has maintained their bullish stance on TMO stock, giving a Buy rating on July 28.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Brandon Couillard has given his Buy rating due to a combination of factors that highlight Thermo Fisher’s strong performance and market positioning. The company’s recent 10-Q filing revealed significant growth in key segments such as Pharma Services, Bioproduction, and the Research/Safety Channel, indicating robust momentum in these areas.
Furthermore, Thermo Fisher appears to be gaining market share, particularly in the Research/Safety Market Channel, where it outperformed competitors like AVTR. Despite some weaknesses in Analytical Instruments, the overall growth in critical segments like BioProduction, which outpaced peers, supports a positive outlook for the company’s stock.

According to TipRanks, Couillard is a 5-star analyst with an average return of 13.8% and a 58.71% success rate. Couillard covers the Healthcare sector, focusing on stocks such as Thermo Fisher, Exact Sciences, and Maravai Lifesciences Holdings.

In another report released on July 28, Scotiabank also maintained a Buy rating on the stock with a $590.00 price target.

Disclaimer & DisclosureReport an Issue

1